At what gestational age should patients with a placental chorangioma be delivered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Delivery for Patients with Placental Chorangioma

Patients with placental chorangioma should be delivered at 34-36 weeks of gestation if stable, with earlier delivery indicated for maternal or fetal complications. 1

Delivery Timing Based on Clinical Presentation

  • For stable patients with placental chorangioma without complications, delivery should be planned between 34-36 weeks of gestation 1
  • Earlier delivery is indicated in cases with maternal or fetal compromise, including: 1
    • Persistent bleeding
    • Preeclampsia
    • Labor or rupture of membranes
    • Fetal compromise (abnormal Doppler studies, growth restriction)
    • Developing maternal comorbidities

Complications Associated with Placental Chorangioma

  • Large placental chorangiomas (>5 cm) are associated with significant maternal and fetal complications: 2, 3
    • Polyhydramnios
    • Preterm labor
    • Postpartum hemorrhage
    • Fetal anemia
    • Fetal distress
    • Fetal hydrops
    • Potential perinatal death

Management Protocol

  • Weekly antenatal monitoring should be implemented after diagnosis of placental chorangioma 2, 3
  • Corticosteroids should be administered if delivery is anticipated before 37 weeks 1
  • Multidisciplinary team involvement with maternal-fetal medicine specialists, anesthesiologists, and neonatologists is recommended 2
  • For large chorangiomas with fetal compromise before viability, consider prenatal interventions such as laser coagulation of feeding vessels in specialized centers 4

Monitoring Parameters

  • Serial ultrasound assessment of:
    • Tumor size and vascularity 5
    • Fetal growth 6
    • Amniotic fluid volume 2
    • Middle cerebral artery Doppler (to detect fetal anemia) 5
    • Umbilical artery Doppler 1

Delivery Considerations

  • Mode of delivery should be individualized based on obstetric indications rather than the presence of chorangioma alone 2
  • Preparation for potential postpartum hemorrhage is essential as placental chorangiomas are associated with uterine atony 2
  • Blood products should be available for both mother and neonate due to risk of maternal hemorrhage and fetal anemia 2, 3

Special Considerations

  • For extremely large chorangiomas (>10 cm) or those with significant fetal compromise, earlier delivery may be necessary, balancing prematurity risks against continued in-utero risks 2, 5
  • In cases of severe fetal growth restriction with abnormal umbilical artery Doppler studies, delivery timing should follow protocols for growth restriction: 1
    • At 37 weeks for decreased diastolic flow without absent/reversed end-diastolic velocity
    • At 33-34 weeks for absent end-diastolic velocity
    • At 30-32 weeks for reversed end-diastolic velocity

Pitfalls to Avoid

  • Delaying delivery beyond 36 weeks in cases of placental chorangioma increases risk of stillbirth 1
  • Failing to prepare for potential neonatal complications, particularly anemia and thrombocytopenia 2
  • Underestimating the risk of postpartum hemorrhage, which requires prophylactic management with uterotonic agents 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Large placental chorioangioma with maternal and perinatal morbidity.

European journal of obstetrics, gynecology, and reproductive biology, 2024

Research

Prenatal laser treatment of a placental chorioangioma.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2005

Research

Placenta chorioangioma: a rare case and systematic review of literature.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2014

Research

Mixed chorangioma and leiomyoma of the placenta, with a brief review of nontrophoblastic placental lesions.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.